Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Atypon full text link Atypon Free PMC article
Full text links

Actions

Share

Comparative Study
.2012 Dec;28(6):618-27.
doi: 10.1089/jop.2012.0040. Epub 2012 Jul 13.

Evaluation of the intravenous and topical routes for ocular delivery of hesperidin and hesperetin

Affiliations
Comparative Study

Evaluation of the intravenous and topical routes for ocular delivery of hesperidin and hesperetin

Ramesh Srirangam et al. J Ocul Pharmacol Ther.2012 Dec.

Abstract

Purpose: The objective of this study was to determine the ocular bioavailability of hesperidin and hesperetin, especially with respect to their distribution into the posterior segment of the eye, following systemic and topical administration in rabbits.

Methods: Hesperidin and hesperetin were administered either intravenously or topically to male New Zealand white (NZW) rabbits. Vitreous humor and plasma samples were collected after intravenous administration and analyzed to estimate the concentrations of the parent compounds and their metabolites. Ocular tissue concentrations, obtained on topical administration of hesperidin and hesperetin, were also determined.

Results: In the systemic circulation, hesperidin and hesperetin were rapidly metabolized into their glucuronides, which are extremely hydrophilic in nature. Vitreal samples did not demonstrate any detectable levels of hesperidin/hesperetin following intravenous administration. Topical administration produced significant concentrations of hesperidin/hesperetin in all the ocular tissues tested at the 1 and 3 hours time points postdosing, with hesperetin showing higher levels compared to hesperidin. However, only low levels were generated in the vitreous humor. Inclusion of a penetration enhancer, benzalkonium chloride (BAK), improved the back-of-the-eye hesperetin levels.

Conclusions: Ocular delivery of hesperidin/hesperetin via the systemic route does not seem to be feasible considering the rapid generation of the hydrophilic metabolites. Topical application appears to be more promising and needs to be further developed/refined.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Selected ion chromatogram and mass spectra of standard compounds (1 μg/mL).
FIG. 2.
FIG. 2.
Mean plasma concentration–time profile of hesperidin and hesperetin-glucuronide (estimated as hesperetin after the treatment of the plasma samples with beta-glucuronidase to convert hesperetin-glucuronide to hesperetin), generatedin vivo, in the rabbits following intravenous administration of hesperidin at 20 mg/kg body weight (n=4).
FIG. 3.
FIG. 3.
Mean plasma concentration–time profile of hesperetin (from direct analysis) and hesperetin-glucuronide (estimated as hesperetin after the treatment of the plasma samples with beta-glucuronidase to convert hesperetin-glucuronide to hesperetin) following intravenous administration of hesperetin at a dose of 20 mg/kg in rabbits (n=4).
FIG. 4.
FIG. 4.
Levels of hesperidin observed in the rabbit ocular tissues at 1 and 3 h following topical administration of hesperidin [100 μL of 1% w/v solution containing HP-β-CD (10% w/v), HPMC (0.1% w/v), 1 N NaOH (0.05% v/v), and 1 N HCl (0.05% w/v), IPBS pH 7.4 (q.s.)]. Values represent mean±SD (n=4). HP-β-CD, hydroxylpropyl beta-cyclodextrin; HPMC, hydroxypropyl methylcellulose; IPBS, isotonic phosphate-buffered saline; SD, standard deviation.
FIG. 5.
FIG. 5.
Levels of hesperetin observed in the rabbit ocular tissues at 1 and 3 h following topical administration of hesperetin [100 μL of 1% w/v solution containing HP-β-CD (10% w/v), HPMC (0.1% w/v), 1 N NaOH (0.05% v/v), and 1 N HCl (0.05% w/v), IPBS pH 7.4]. Values represent mean±SD (n=4).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ciulla T.A. Amador A.G. Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care. 2003;26:2653–2664. - PubMed
    1. Chiou G.C. Xu X.R. Effects of some natural flavonoids on retinal function recovery after ischemic insult in the rat. J. Ocul. Pharmacol. Ther. 2004;20:107–113. - PubMed
    1. Calderone V. Chericoni S. Martinelli C., et al. Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels. Naunyn Schmiedebergs Arch. Pharmacol. 2004;370:290–298. - PubMed
    1. Manthey J.A. Biological properties of flavonoids pertaining to inflammation. Microcirculation. 2000;7:S29–S34. - PubMed
    1. Bouskela E. Cyrino F.Z. Marcelon G. Inhibitory effect of the Ruscus extract and of the flavonoid hesperidine methylchalcone on increased microvascular permeability induced by various agents in the hamster cheek pouch. J. Cardiovasc. Pharmacol. 1993;22:225–230. - PubMed

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full text links
Atypon full text link Atypon Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2025 Movatter.jp